Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dow

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|March 24, 2018
2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based SafetyRobert L Dow, Mark Ammirati, Scott W Bagley, et al.
Plos One|March 31, 2015
Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in ratsAntonia L Dow, Tiffany V Lin, Elena H Chartoff, et al.
Physical Medicine and Rehabilitation Clinics of North America|January 14, 2012
The paradox of muscle hypertrophy in muscular dystrophyJoe N Kornegay, Martin K Childers, Daniel J Bogan, et al.
BMC Pharmacology|August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonistJohn R Hadcock, Philip A Carpino, Philip A Iredale, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1Robert L Dow, Jian-Cheng Li, Michael P Pence, et al.
The Journal of Organic Chemistry|November 7, 2012
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitorsKim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, et al.
Skeletal Muscle|April 6, 2016
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contracturesJoe N Kornegay, Daniel J Bogan, Janet R Bogan, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonistsPhilip A Carpino, David A Griffith, Subas Sakya, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimeticsRobert L Dow, Steven R Schneider, Ernest S Paight, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|March 24, 2018
2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based SafetyRobert L Dow, Mark Ammirati, Scott W Bagley, et al.
Plos One|March 31, 2015
Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in ratsAntonia L Dow, Tiffany V Lin, Elena H Chartoff, et al.
Physical Medicine and Rehabilitation Clinics of North America|January 14, 2012
The paradox of muscle hypertrophy in muscular dystrophyJoe N Kornegay, Martin K Childers, Daniel J Bogan, et al.
BMC Pharmacology|August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonistJohn R Hadcock, Philip A Carpino, Philip A Iredale, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1Robert L Dow, Jian-Cheng Li, Michael P Pence, et al.
The Journal of Organic Chemistry|November 7, 2012
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitorsKim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, et al.
Skeletal Muscle|April 6, 2016
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contracturesJoe N Kornegay, Daniel J Bogan, Janet R Bogan, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonistsPhilip A Carpino, David A Griffith, Subas Sakya, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimeticsRobert L Dow, Steven R Schneider, Ernest S Paight, et al.
Pageof 17